Lake, Paige W.Head, Katharine J.Christy, Shannon M.DeMaria, Andrea L.Thompson, Erika L.Vadaparampil, Susan T.Zimet, Gregory D.Kasting, Monica L.2023-06-272023-06-272022-04-20Lake PW, Head KJ, Christy SM, et al. Association between patient characteristics and HPV vaccination recommendation for postpartum patients: A national survey of Obstetrician/Gynecologists. Prev Med Rep. 2022;27:101801. Published 2022 Apr 20. doi:10.1016/j.pmedr.2022.101801https://hdl.handle.net/1805/33982Human papillomavirus (HPV) vaccination rates in the U.S. are relatively low. Provider recommendation rates for HPV vaccination often vary by patient age and relationship status. Obstetrician/gynecologists (OB/GYNs) represent a key provider group that can recommend the HPV vaccine. This study examined differences in OB/GYN recommendation of HPV vaccination for inpatient postpartum patients by age, parity, and marital status. Data were collected from OB/GYNs nationally via a cross-sectional survey. Participants were randomized to two vignette groups (23-year-old patient or 33-year-old patient). Within each group, participants received 4 vignettes that were identical except for patient marital status (married/not in a committed relationship) and number of children (first/third child), and were asked to indicate HPV vaccination recommendation likelihood on a scale of 0 (definitely would not) to 100 (definitely would). A 2 × 2 × 2 general linear model with repeated measures was used to examine main and interaction effects of patient age, relationship status, and parity. 207 OB/GYNs were included in the final analyses. Recommendation was high for 23-year-old patients (range: 64.5-84.6 out of 100). When marital status and parity were held constant, recommendation likelihood was higher for the younger vs. older patient and was also higher for patients not in a committed relationship, compared to married patients (all p-values < 0.001). Differences in recommendation exist when considering age and relationship status, which provides insight into OB/GYN clinical decision-making. Findings highlight the need to address barriers to HPV vaccination recommendation, including awareness of risk factors to consider when recommending the vaccine.en-USAttribution-NonCommercial-NoDerivatives 4.0 InternationalHuman papillomavirus vaccineObstetricsGynecologySurveysPostpartum periodClinical decision-makingHPV vaccineArticle